258 related articles for article (PubMed ID: 37087975)
1. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1.
Cheff DM; Huang C; Scholzen KC; Gencheva R; Ronzetti MH; Cheng Q; Hall MD; Arnér ESJ
Redox Biol; 2023 Jun; 62():102703. PubMed ID: 37087975
[TBL] [Abstract][Full Text] [Related]
2. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
[TBL] [Abstract][Full Text] [Related]
3. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
[TBL] [Abstract][Full Text] [Related]
4. Slowly progressive cell death induced by GPx4-deficiency occurs via MEK1/ERK2 activation as a downstream signal after iron-independent lipid peroxidation.
Tsuruta K; Matsuoka M; Harada S; Enomoto A; Kumagai T; Yasuda S; Koumura T; Yamada KI; Imai H
J Clin Biochem Nutr; 2024 Mar; 74(2):97-107. PubMed ID: 38510679
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis.
Jelinek A; Heyder L; Daude M; Plessner M; Krippner S; Grosse R; Diederich WE; Culmsee C
Free Radic Biol Med; 2018 Mar; 117():45-57. PubMed ID: 29378335
[TBL] [Abstract][Full Text] [Related]
6. Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death.
Probst L; Dächert J; Schenk B; Fulda S
Biochem Pharmacol; 2017 Sep; 140():41-52. PubMed ID: 28595877
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3ε.
Vučković AM; Bosello Travain V; Bordin L; Cozza G; Miotto G; Rossetto M; Toppo S; Venerando R; Zaccarin M; Maiorino M; Ursini F; Roveri A
FEBS Lett; 2020 Feb; 594(4):611-624. PubMed ID: 31581313
[TBL] [Abstract][Full Text] [Related]
8. A tangible method to assess native ferroptosis suppressor activity.
Nakamura T; Ito J; Mourão ASD; Wahida A; Nakagawa K; Mishima E; Conrad M
Cell Rep Methods; 2024 Mar; 4(3):100710. PubMed ID: 38401540
[TBL] [Abstract][Full Text] [Related]
9. A white paper on Phospholipid Hydroperoxide Glutathione Peroxidase (GPx4) forty years later.
Ursini F; Bosello Travain V; Cozza G; Miotto G; Roveri A; Toppo S; Maiorino M
Free Radic Biol Med; 2022 Aug; 188():117-133. PubMed ID: 35718302
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of ferroptosis.
Cao JY; Dixon SJ
Cell Mol Life Sci; 2016 Jun; 73(11-12):2195-209. PubMed ID: 27048822
[TBL] [Abstract][Full Text] [Related]
11. Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer.
Sekhar KR; Hanna DN; Cyr S; Baechle JJ; Kuravi S; Balusu R; Rathmell K; Baregamian N
Sci Rep; 2022 Nov; 12(1):19396. PubMed ID: 36371529
[TBL] [Abstract][Full Text] [Related]
12. Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis.
Chen M; Shi Z; Sun Y; Ning H; Gu X; Zhang L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675129
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of ferroptosis and their involvement in brain diseases.
Costa I; Barbosa DJ; Benfeito S; Silva V; Chavarria D; Borges F; Remião F; Silva R
Pharmacol Ther; 2023 Apr; 244():108373. PubMed ID: 36894028
[TBL] [Abstract][Full Text] [Related]
14. Cysteine and homocysteine can be exploited by GPX4 in ferroptosis inhibition independent of GSH synthesis.
Xia C; Xing X; Zhang W; Wang Y; Jin X; Wang Y; Tian M; Ba X; Hao F
Redox Biol; 2024 Feb; 69():102999. PubMed ID: 38150992
[TBL] [Abstract][Full Text] [Related]
15. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1.
Miotto G; Rossetto M; Di Paolo ML; Orian L; Venerando R; Roveri A; Vučković AM; Bosello Travain V; Zaccarin M; Zennaro L; Maiorino M; Toppo S; Ursini F; Cozza G
Redox Biol; 2020 Jan; 28():101328. PubMed ID: 31574461
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
17. GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis.
Forcina GC; Dixon SJ
Proteomics; 2019 Sep; 19(18):e1800311. PubMed ID: 30888116
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and regulations of ferroptosis.
Zhang XD; Liu ZY; Wang MS; Guo YX; Wang XK; Luo K; Huang S; Li RF
Front Immunol; 2023; 14():1269451. PubMed ID: 37868994
[TBL] [Abstract][Full Text] [Related]
19. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration.
Carlson BA; Tobe R; Yefremova E; Tsuji PA; Hoffmann VJ; Schweizer U; Gladyshev VN; Hatfield DL; Conrad M
Redox Biol; 2016 Oct; 9():22-31. PubMed ID: 27262435
[TBL] [Abstract][Full Text] [Related]
20. Oxytosis/Ferroptosis in Neurodegeneration: the Underlying Role of Master Regulator Glutathione Peroxidase 4 (GPX4).
Dar NJ; John U; Bano N; Khan S; Bhat SA
Mol Neurobiol; 2024 Mar; 61(3):1507-1526. PubMed ID: 37725216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
